What is the BforCure plateform?
A revolutionary portable biodetection plateform adressing a wide range of markets such as Defense, Healthcare, Environment & Research.
It delivers in less than 15 minutes from sample to results with state of the art sensitivity and accuracy performance.
Our expertise
BforCure team gathers experts in microfluidics, molecular biology, microbiology, advanced mechanical design, thermal management, electrical engineering, system engineering, bioinformatics, software, etc... to solve the most challenging problems of bio-detection. Based on the patented Fastgene technology, our first products use quantitative polymerase chain reaction (qPCR) to achieve ultra-fast, ultra -sensitive multiplex assays.
Promising company
BforCure technology won the "Laureate of the World Innovation 2030 Challenge" for innovative ideas and technologies.
It was awarded a €8M funding by the French General Secretary for investment to become a “future potential world leader of the medical diagnostic market based on microfluidic technologies”.
Investors & corporates
If you are an investor or a corporate and you want to be part of the next revolution of diagnostic, do not hesitate to contact us at contact@bforcure.com, we are always open to new fruitful partnerships.
Management
An association of experienced entrepreneurs
Maël LE BERRE, PhD
CEO
Georges SALEM, MD
COO
Christophe PANNETIER, PhD
CSO
Cyril CERVEAU
General Manager
Our partners & sponsors
